HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine
HLA-A2.1 限制性 ECM1 衍生表位 LA 通过 DC 交叉激活引发 CD8+ T 和 NK 细胞:一种新型治疗性肿瘤疫苗
期刊:Journal of Hematology & Oncology
影响因子:29.5
doi:10.1186/s13045-021-01081-7
Zhaojin Yu #, Wensi Liu #, Ying He #, Mingli Sun, Jiankun Yu, Xue Jiao, Qiang Han, Haichao Tang, Bing Zhang, Yunkai Xian, Jing Qi, Jing Gong, Wang Xin, Gang Shi, Fengping Shan, Rui Zhang, Jianping Li, Minjie Wei